Refine
Document Type
- Doctoral Thesis (2)
Language
- English (2)
Has Fulltext
- yes (2)
Is part of the Bibliography
- no (2)
Keywords
- Aeromonas salmonicida (2) (remove)
Institute
Rainbow trout (Oncorhynchus mykiss) represents the third most produced species of diadromous fish, with the total production of 0,732 million tonnes in 2009. More than one third of this production comes from Europe, where it is dominated by Norway, Italy and France. Germany is the fifth biggest producer in Europe, producing 21 thousand tonnes of rainbow trout in the value of 6,1 million Euro. However, the conditions in the intensive aquaculture often increase the disease susceptibility to many pathogens. One of the highest economic threats for a salmonids aquaculture is the causative agent of furunculosis, Aeromonas salmonicida subsp. salmonicida. Several strategies have been developed to protect the fish, but the traditional methods are either laborious or represent a potential risk for the environment. The selective breeding established more than 35 years ago in the brackish waters of Baltic Sea represent a attractive alternative, delivering a novel strain of rainbow trout better adapted to the brackish environment and exhibiting reduced mortality in the infection with A.salmonicida. Nevertheless, no information was available about the fundaments of this phenomenon. Thus, the aim of presented study was the identification of immune adaptations, which occurred during the 30 years of selection and favoured increased survival of “born” trout to the bacterial diseas es. In the presented work, the peritoneal cavity of rainbow trout has been used as a model for the investigation of disease resistance in fish. In the first chapter, the peritoneal cavity has been described as a unique niche of teleost immune system and the kinetic of peritoneal leukocytes induced by the stimulation has been analysed. Furthermore, a unique set of monoclonal antibodies has been used to evaluate the contribution of distinct cell populations on the inflammation and its resolution. In the second part of the study, the transcriptional changes of peritoneal leukocytes have been evaluated using the GRASP microarray. The following analysis provided unique insights into the local immune response in rainbow trout. The unprecedented combination of both data sets offers an unparalleled description of the local immune response in teleost fish and can be summarized into following facts. In general, the obtained results revealed, that the unstimulated peritoneal cavity is populated predominantly by lymphocytes with IgM+ Bcells being the major cells type. The rapid changes in the composition induced by the stimulation were underlined by the upregulation of major proinflammatory molecules such as IL1β, IL8 and TNFα within 12hpi. Although the initial phase of the reaction was dominated by myeloid cells, the cavity underwent within 72 hours two complete changes in the composition corresponding with the massive changes in the transcriptome. Eventually, the resolution of inflammation was marked by an increasing number of lymphocytes and correlated with the downregulation of pro-inflammatory genes to the initial level and upregulation of anti-inflammatory cytokines IL10 and TGFβ. Besides the general observations common to all treatments and both strains, our experiments revealed also remarkable differences between the antigenic stimulation and reaction towards pathogen. From these differences following conclusions can be drawn; the infection induces comparable reaction pattern as the stimulation, although the intensity of the reaction and number of cells is higher. These observations correlated with the higher expression of inflammatory molecules after the infection. Viable bacteria also prolong the myeloid phase of the reaction and delay the resolution of inflammation. Finally, model of peritoneal inflammation caused by A. salmonicida has been applied also to the second strain of rainbow trout, known for its higher resistance to infection. The comparison of obtained data suggested that resistant trout reacted to the antigenic stimulation and infection with a lower number of cells despite minor differences in the expression level of major pro-inflammatory molecules during early stages of the infection. Eventually, the resolution of inflammation and onset of adaptive immune response occurred in resistant trout almost 24 hours earlier and was correlating with an increased expression of anti-inflammatory cytokines IL10 and TGFβ. Notably, the increased survival of resistant strain correlates with the increased expression of antibacterial proteins such as NRAMP and hepcidin. Taken together, obtained data provided unprecedented insights into the local immune response in teleost fish and identified features conserved during the selection breeding in the brackish water of Baltic Sea. Additionally, combination of cellular and molecular data elucidates the peritoneal inflammation in fish and suggested high conservation of the immune response in the evolution.
Gram-negative bacteria are known to naturally produce outer membrane vesicles (OMVs), which are closed nanoparticles (10 to 450 nm) containing virulence factors and pathogen associated molecular patterns (PAMPs). For over 20 years, OMVs of Neisseria meningitidis (N. meningitidis), in combination with three purified outer membrane proteins, have been successfully used as parts of human vaccines which illustrates the safety and potential of OMV based vaccines. So far only little is known about the OMVs of fish pathogenic bacteria. The production of OMVs has been described for the fish pathogenic gram-negative bacterium Aeromonas salmonicida (A. salmonicida) which is the causative agent of furunculosis resulting in high morbidity and mortality of salmonid fish. The immunostimulatory potential of OMVs derived from A. salmonicida as well as the possibility of establishing an oral vaccine model in Oncorhynchus mykiss (O.mykiss) (Rainbow trout) has been investigated in this study by conducting in vitro and in vivo experiments. Innate immune cells such as macrophages are one of the first cells to respond to pathogens once they breach the skin barrier, therefore the monocyte/macrophage cell line RTS-11 as well as leukocytes from the head kidney, consisting of a high percentage of phagocytic cells have been investigated. Additionally, leukocytes isolated from the peritoneal cavity as the main target for injectable vaccines have been studied in the in vitro experiments. These experiments indicate that OMVs derived from A. salmonicida are recognized by the monocyte/macrophage cell line RTS-11 as well as by leukocytes from the head kidney resulting in significant changes of the mRNA expression pattern of early inflammatory markers (IL-1β, IL-6, IL-8, IL-10, TGFβ). Having used the established peritoneal inflammation model of rainbow trout it could be shown that intraperitoneal (i.p.) vaccination of rainbow trout with OMVs results in a similar local immune response, especially in the recruitment of myeloid cells, compared to the injection of inactivated bacteria. The systemic cellular immune response differed between the two vaccine groups, even though a similar humoral immune response could be observed. Interestingly, i.p.vaccination with 10 µg of OMVs resulted in similar antibody titers as observed for fish, that were i.p. vaccinated with 108 CFU of inactivated A. salmonicida. The similar antibody titers after vaccination with OMVs might be explained by a stronger activation of CD8- T cells (likely CD4+ T cells) in the head kidney as well as in the blood in the OMV vaccinated group alone, which might result in an increased stimulation of B cells to produce antibodies.
Oral vaccination has been described as the ideal vaccination method for fish, but only few vaccines for oral application are licensed. Therefore, the established oral model for vaccination of rainbow trout with attenuated viral hemorrhagic septicemia virus (VHSV) was adapted to be used for inactivated A. salmonicida, even though initial trials indicated great similarities in the cellular response after i.p. and oral vaccination with inactivated strains of A. salmonicida, particularly in the response of the myeloid cells and lymphocytes in the target organs as well as the thrombocytes in the spleen. This could not be confirmed in a second oral vaccination trial. These results show how challenging the development of oral vaccines for fish is. The main challenge is the reproducibility of reliable results, since this is influenced by the difference in uptake of vaccine pellets or antigen degradation in the gut. Future oral vaccine trials should investigate different vaccination regimes, e.g., consecutive feeding, or a different composition of vaccine pellets, in order to further investigate the possibility of establishing an oral vaccine model for trout and so that future vaccine candidates, like OMVs, can be reliably tested in fish.